Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides ...

The updated labeling includes the immunogenicity and safety data from an open-label, multicenter phase 3 trial (NCT01954251) of 828 adults aged ≥50 years who received either Fluarix Quadrivalent ...

GlaxoSmithKline announced it has begun shipping the 2015-2016 formulation of Fluarix Quadrivalent (influenza virus vaccine) and expects to begin shipping Flulaval Quadrivalent (influenza virus ...

"The expanded indication for FLUARIX ® QUADRIVALENT in the US builds upon GSK's commitment to being a reliable supplier and partner to healthcare providers and their patients. We can now offer ...

The TGA has agreed that the Fluarix vaccine can continue to be used, but it advises doctors to visually inspect the pre-filled syringes prior to administration.

CNPC, Asia's top oil producer, is reviewing its global strategy as it looks to revive dealmaking, eyeing gas liquefaction and deepsea drilling as well as building on its record of producing more ...

The U.S. Food and Drug Administration has approved Fluarix Quadrivalent to immunize children age 3 and older and adults against flu virus subtypes A and B contained in the vaccine. It is the first ...